- Investing Ideas
- U.K. Healthcare Undervalued over 20% based on DCF
U.K. Healthcare Undervalued over 20% based on DCF
Results
5
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
5 companies
Smith & Nephew
Market Cap: UK£9.0b
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
SN.
UK£10.70
7D
-2.4%
1Y
-22.7%
Convatec Group
Market Cap: UK£4.4b
Engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally.
CTEC
UK£2.26
7D
-1.6%
1Y
-6.9%
Advanced Medical Solutions Group
Market Cap: UK£610.3m
Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally.
AMS
UK£2.82
7D
0.2%
1Y
35.3%
NIOX Group
Market Cap: UK£288.7m
Engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide.
NIOX
UK£0.69
7D
1.5%
1Y
-1.4%
EKF Diagnostics Holdings
Market Cap: UK£109.3m
Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.
EKF
UK£0.25
7D
0.4%
1Y
-6.1%